Bobak Azamian, MD, PhD retweeted
At least 185 Iranians have been killed while protesting for freedom.
I introduced a bipartisan, bicameral resolution commending those who are demanding freedom & justice. It's co-sponsored by 36 members of the House & 10 Senators, with support growing!
tenney.house.gov/media/press…
Bobak Azamian, MD, PhD retweeted
Dear world leaders, we need more than hope and prayers when teenagers are being gunned down in the streets and in their schools. We need action. #OpIran #MahsaAmini #Remembertheirnames @1000daysband
Bobak Azamian, MD, PhD retweeted
2022 #PharmaVoice100 Entrepreneurs
Bobak @azamian
@DawnBarryDNA
Beth Crouse
Samantha Du
Jeff Fischer
David Katz
@VincentKeunen
Kathy Lee-Sepsick
@NelloMainolfi
@pk_manasco
Andrew Miller
@DrLauraNiklason
@johnvoyler
@ArmonSharei
@kuldeepx
Nina Wachsman
pharmavoice.com/news/pv100-p…
Bobak Azamian, MD, PhD retweeted
In Persian, when behavior comes naturally and effortlessly to someone they say it’s “like they’re drinking water”. The way the Iranian regime’s security forces nonchalantly shoot unarmed civilians (near Sharif University) is like they’re drinking water.
We have something for those ticks!! @TarsusRx
2
Bobak Azamian, MD, PhD retweeted
"Every moment in darkness is a mortal threat to another young woman." Computational geneticist Dr. Pardis Sabeti dedicates her TIME100 Impact Award to Mahsa Amini and the protesters in Iran ti.me/3rpVzSs
TIME100 Impact Awards: Pardis Sabeti Speech
Bobak Azamian, MD, PhD retweeted
Our team is having a great time at #AAO2022. Thank you @DGlaucomflecken and many others for celebrating with us!
Bobak Azamian, MD, PhD retweeted
Getting ready for the Folliculorum Feud!! @TarsusRx @ericdonnenfeld @LizYeu @nedashamie @zaina1225 @LookattheLids
Bobak Azamian, MD, PhD retweeted
I invite feminists and freedom fighters around the world, to join us supporting the Iranian women and people’s uprising against Iranian regime. We don’t need you to save us, but we need West to stop saving this regime. Join us calling them out.
#مهسا_امینی
#IranRevolution
Bobak Azamian, MD, PhD retweeted
Honored to be a finalist for @Citeline_Awards Clinical Trial Result of the Year for our Phase 2b/3 Saturn-1 pivotal trial evaluating the safety and efficacy of our lead investigational product for the treatment of Demodex blepharitis. https://teapawt.net/t.co/JFSEj1k1bD #CitelineAwards
Bobak Azamian, MD, PhD retweeted
We are proud to be featured in the @NewYorker for our work developing a preventative therapy for Lyme disease. To learn more about the future of Lyme disease prevention, including the science behind our lead candidate, read the article below. #lymedisease #ticks #tickseason
The F.D.A. approved the first Lyme vaccine in 1998. Then, in a rare occurrence in modern medicine, it disappeared. nyer.cm/jGSvfnW
Bobak Azamian, MD, PhD retweeted
If you wanna take a break from worrying about Covid, you have mites in your eyelashes and always have
Thrilled to bring on two new leaders to help us build a great company and scale our passion for delivering new therapies!
Tarsus is building an experienced leadership team to help us achieve our mission of bringing transformational new drugs to patients with unmet needs, starting with Demodex Blepharitis
#demodex #blepharitis #optometry #ophthalmology
prnewswire.thumbs.top/67Mvo
Bobak Azamian, MD, PhD retweeted
There are 2.1M diagnoses of blepharitis each year, but no FDA-approved treatments. The Jupiter study evaluated the safety & efficacy of TP-03 for the treatment of Demodex Blepharitis. Read the AOA poster presentation to see how well it did: hubs.ly/H0s0MP90 #ad @tarsusrx
Bobak Azamian, MD, PhD retweeted
Check out our exciting new data from a randomized controlled study of TP-03 to treat Demodex Blepharitis!
There are 2.1M diagnoses of blepharitis each year, but no FDA-approved treatments. The Jupiter study evaluated the safety & efficacy of TP-03 for the treatment of Demodex Blepharitis. Read the AOA poster presentation to see how well it did: hubs.ly/H0s0MP90 #ad @tarsusrx
Bobak Azamian, MD, PhD retweeted
Check out the positive Phase 2b RCT Jupiter Study results of TP-03 to Treat Demodex Blepharitis that were presented at the AOA 2020 Virtual Meeting!
#demodex #blepharitis #optometry #ophthalmology
tarsusrx.com/jupiter-study
Bobak Azamian, MD, PhD retweeted
Check out the highlights of the Mars Phase 2a study of the safety and efficacy of TP-03 for Demodex Blepharitis!
#demodex #blepharitis #optometry #ophthalmology #innovation
eyetube.net/collections/tars…




















